THE COST EFFECTIVENESS OF AFAMELANOTIDE FOR THE TREATMENT OF ERYTHROPOIETIC PROTOPORHYRIA
May 1, 2016, 00:00 AM
10.1016/j.jval.2016.03.1067
https://www.valueinhealthjournal.com/article/S1098-3015(16)01135-9/fulltext
Section Title :
Systemic Disorders/Conditions - Cost Studies
Section Order :
914
First Page :
A248
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)01135-9&doi=10.1016/j.jval.2016.03.1067